EUVIMEDEUVIMED entdecken
Crossref

Isoliquiritigenin attenuates neuroinflammation after subarachnoid hemorrhage through inhibition of NF‐κB ‐mediated NLRP3 inflammasome activation

Zhang Wenfei, Tao Xiang, Chen Chen, Tao Yang, Tao Yun, Chen Zhibiao, Zhang Ge

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Zhang Wenfei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage, Brain Injuries, Chalcones. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroinflammation contributes to neurological dysfunction in the patients who suffer from subarachnoid hemorrhage (SAH). Isoliquiritigenin (ISL) is a bioactive component extracted from Genus Glycyrrhiza . This work is to investigate whether ISL ameliorates neuroinflammation after SAH. In this study, intravascular perforation of male Sprague–Dawley rats was used to establish a SAH model. ISL was administered by intraperitoneal injection 6 h after SAH in rats. The mortality, SAH grade, neurological score, brain water content, and blood–brain barrier (BBB) permeability were examined at 24 h after the treatment. Expressions of tumor necrosis factor‐α, interleukin‐6, Iba‐1, and MPO were measured by quantitative real‐time polymerase chain reaction (qRT‐PCR). Besides, the expression levels of NF‐κB p65 and NLRP3, ASC, caspase‐1, IL‐1β, and IL‐18 were analyzed by western blot. The experimental data suggested that ISL treatment could ameliorate neurological impairment, attenuate brain edema, and ameliorate BBB injury after SAH in rats. ISL treatment repressed the expression of proinflammatory cytokines TNF‐α and IL‐6, and meanwhile inhibited the expression of Iba‐1 and MPO. ISL also repressed NF‐κB p65 expression as well as the transport from the cytoplasm to the nucleus. In addition, ISL significantly suppressed the expression levels of NLR family pyrin domain containing 3 (NLRP3), ASC, caspase‐1, IL‐1β, and IL‐18. These findings suggest that ISL inactivates NLRP3 pathway by inhibiting NF‐κB p65 translocation, thereby repressing the neuroinflammation after SAH, and it is a potential drug for the treatment of SAH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Subarachnoid HemorrhageBrain InjuriesChalconesHumansRatsMaleAnimalsNF-kappa BInflammasomesRats, Sprague-DawleyNLR Family, Pyrin Domain-Containing 3 ProteinInterleukin-18Neuroinflammatory DiseasesTumor Necrosis Factor-alphaCaspases

Stichwörter der Autor:innen

ISLNF-κBNLRP3Neuroinflammationsubarachnoid hemorrhage

Substanzen

NF-kappa BInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinInterleukin-18isoliquiritigeninTumor Necrosis Factor-alphaCaspasesChalcones

Autor:innen und Institutionen

  • Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
  • Department of Orthodontics, Wuhan First Stomatological Hospital, Wuhan, China.
  • Department of Nursing, Renmin Hospital of Wuhan University, Wuhan, China.
  • Department of Stomatology, Wuhan Central Hospital, Wuhan, China.

Zitieren

APA

Wenfei, Z., Xiang, T., Chen, C., Yang, T., Yun, T., Zhibiao, C., & Ge, Z. (2024). Isoliquiritigenin attenuates neuroinflammation after subarachnoid hemorrhage through inhibition of NF‐κB ‐mediated NLRP3 inflammasome activation. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14436

Vancouver

Wenfei Z, Xiang T, Chen C, Yang T, Yun T, Zhibiao C, et al. Isoliquiritigenin attenuates neuroinflammation after subarachnoid hemorrhage through inhibition of NF‐κB ‐mediated NLRP3 inflammasome activation. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14436

BibTeX
@article{Wenfei2024,
  author = {Wenfei, Zhang and Xiang, Tao and Chen, Chen and Yang, Tao and Yun, Tao and Zhibiao, Chen and Ge, Zhang},
  title = {Isoliquiritigenin attenuates neuroinflammation after subarachnoid hemorrhage through inhibition of NF‐κB ‐mediated NLRP3 inflammasome activation},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14436}
}
Kostenlos starten →